IFT57 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.383600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.342800E-01
Normal-vs-Stage2
4.645900E-02
Normal-vs-Stage3
1.147660E-02
Normal-vs-Stage4
4.561800E-02
Stage1-vs-Stage2
2.176600E-01
Stage1-vs-Stage3
5.616500E-02
Stage1-vs-Stage4
6.959600E-01
Stage2-vs-Stage3
2.495200E-01
Stage2-vs-Stage4
5.078400E-01
Stage3-vs-Stage4
6.381900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.505700E-02
Normal-vs-AfricanAmerican
5.335600E-01
Normal-vs-Asian
2.158100E-02
Caucasian-vs-AfricanAmerican
1.249350E-01
Caucasian-vs-Asian
4.161600E-01
AfricanAmerican-vs-Asian
9.110000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.510500E-02
Normal-vs-Female
2.335900E-02
Male-vs-Female
6.016000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.089200E-01
Normal-vs-Age(41-60Yrs)
2.695600E-01
Normal-vs-Age(61-80Yrs)
1.123760E-02
Normal-vs-Age(81-100Yrs)
1.453950E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.911800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.364000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.459600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.959300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.482000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.755800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.238100E-03
Normal-vs-Daily Drinker
2.026200E-02
Normal-vs-Weekly Drinker
8.919200E-03
Normal-vs-Occasional Drinker
5.187400E-01
Normal-vs-Social Drinker
2.666400E-02
Non Drinker-vs-Daily Drinker
3.932000E-01
Non Drinker-vs-Weekly Drinker
8.623800E-01
Non Drinker-vs-Occasional Drinker
1.496630E-01
Non Drinker-vs-Social Drinker
7.649000E-01
Daily Drinker-vs-Weekly Drinker
6.106000E-01
Daily Drinker-vs-Occasional Drinker
2.980200E-01
Daily Drinker-vs-Social Drinker
7.117200E-01
Weekly Drinker-vs-Occasional Drinker
1.947360E-01
Weekly Drinker-vs-Social Drinker
9.165600E-01
Occasional Drinker-vs-Social Drinker
2.307400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.096100E-02
Normal-vs-Grade 2
2.590100E-02
Normal-vs-Grade 3
1.260150E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.162000E-01
Grade 1-vs-Grade 3
5.244600E-01
Grade 1-vs-Grade 4
7.096100E-02
Grade 2-vs-Grade 3
5.638200E-02
Grade 2-vs-Grade 4
2.590100E-02
Grade 3-vs-Grade 4
1.260150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.924300E-03
Normal-vs-NonDiabetic
7.997700E-02
Diabetic-vs-NonDiabetic
1.895820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.236400E-02
Normal-vs-NoPancreatitis
5.936400E-02
Pancreatitis-vs-NoPancreatitis
7.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.831800E-02
Normal-vs-N1
6.301800E-02
N0-vs-N1
9.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.083800E-01
Normal-vs-TP53-NonMutant
1.314590E-01
TP53-Mutant-vs-TP53-NonMutant
7.187800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
